BE697097A - - Google Patents
Info
- Publication number
- BE697097A BE697097A BE697097DA BE697097A BE 697097 A BE697097 A BE 697097A BE 697097D A BE697097D A BE 697097DA BE 697097 A BE697097 A BE 697097A
- Authority
- BE
- Belgium
- Prior art keywords
- desc
- page number
- clms page
- washed
- never
- Prior art date
Links
- 238000010992 reflux Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<Desc/Clms Page number 1>
EMI1.1
;;IQ1{I#1 t1ïdi@&lett. :1"F3. :â.-''.W'-y at h:2ré'Sß"w. pOtâ1: sa prÉpt1.>it:::
EMI1.2
La présent invention sï ..i:':: un compoz4 chimique nowiweau, doué ds prcpsiétês 33'->5Î:32;-3.i9'cy.fâ qui en font un Yi3.rtYfkI1' utils4 ainsi 1}à un procédé pour sa prépara" tion* Ce composé est le . 3, t x'rae acsa.3 de I.mla m.n-tnr3..
de formule
EMI1.3
Il se présente sous forme de cristaux blancs P.F 135-137 Outrés solubles-dans l'eau, solubles dans le mé- -thanol et l'acétone, insolubles dans les autres solvants organiques usuels,
<Desc/Clms Page number 2>
EMI2.1
on le prépare par réaction d l'acide 1,35trimêthoxy- benzoique sur le chlorure de diméthylaminoéthyle en solution dans la méthyléthylcétone, à chaud soue reflux,
A titre d'exemple on donne ci-après un mode opératoire de cette réactin
Dans un ballon de 500ml à 3 tubulures on introduit
EMI2.2
J1..!:) çg (Qg!.5 -e4*acldo t3j,S''toxybeasoqMo 22,6 gj !oô l,57 ?i) c ci.iS,Y:;ori:
de ditnétylasdnoétle et 50 < de esrbTi#a>r ,]e #Jima>oeLu;, vn sellit4lon dans 250 >1 de iBtbyl" 0ényicisicac et 3 1'lÔ. iPI{;!.MJ On chauffe coum efl <78 c) gù;xiJa#:'= 4 **xas a a-a >;afioÉ.41i.si;enTàit , fil%55&rL=<:36 law>##ç.i :: In #:.ùzà#jrl=àth;/>,càton< it soue '11id(1 en. oà;.tàei<;t 6 <a yt,<àu=ii brttt iP:,iur js'iëies' go pr(;t1I,:i;;: 'b1?u?, on le >? ç#=::?nÙ aHS He 1 r±'4th.ar, Q on .-e lave aes 10 ml PU4-s ayee 3C0 %1. d'uno+ soluëisn aqueuse gaturâe de enrbonate de oo4iu#j pais à ;okzv7eaù avas 100 ml d'eau, On sëchs 1 f t:her aur sc 4N?'2 on filtre, on lave à nouveau à l'éther et on évapore à sec ce qui donne 22g de produit purifié.
On peut pousser plus loin la purification en reprenant. ce produit par 200 ml d'acétone en traitant sur charbon et en filtrant, On acidifie alors à PH 4-5 au moyen de HBr aquax à 63% puis on laisse cristalliser ; âpres évaporation à se , on reprend par 100 ml d'acétate d'éthyle, essora, 'lave, sèche, puis on reprend à nouveau dans 70 ml d'isopropanol à reflux, traite au charbon, filtre à chaud, cristallise, es- sore, lave à l'isopropanol et enfin sèche sous vide à 50 c
<Desc/Clms Page number 3>
EMI3.1
5 hra ossda ls s$ia Odyn -amî ' - $ :
.rsur sa8y$ c .a és $e¯rûig. tsLonwcë a 5 --mg/kg zut :tçn -Pro -gr- ev- Ss'Beà';5@lH p- -a-r- 0,1- fîe sss L-;.?"4 46te=Lnent mne s s :.s garotlaienne ïtnt'lasx s - ss ¯o"":- nue- 7.Y3R33 et- ü3 .sa'3'ü.â al3:-=.s ìs ' 125 â -45 -mîr .12tes w- ¯ action a- .petroaKa Qm3 3.a it est ais -51trê pàr -vol -sss!3' -i-' ..'1 Chez -rat-, -aïnc ddses mwennes dé -3:=2 -tranqui .s -ies -doseïj as 3 efl.ës 3:= 3ai pro-voque --P" ds ïr.tl.o assta3s z drotanîne -1-Rvie e--nôtér-- 3¯= aii :¯a::a.s- s oas$ n or -13a phênts poteeuTst.u#sJ rte'<Na!jLaêse -=.s'-â g ,
<Desc/Clms Page number 4>
EMI4.1
'!M[ua9 sre, -'-' "- "''-' ,,-;,,9n;p;;vlr;'éë produit comme méëliçbt:i1ypàtêji;; im5!i;i;f?o8 dosés à 50-loo avec 1 admîniatrd a raison 4e 1 à 3 compr1m6s '#5 jour#*- notamment -pour -,le' traitement de 1 II.Wpertension de .
(, j¯¯ oimquantaine , , - ' m ; - il¯ ' i ' . =' ' - ' )=( 1] .-.. ainsi, comme'.1a réserpine on- ses dr!Yéa' Ç.lors qu Ill ist 1>iacti± dan* loe¯,òrmea Jévérea à¯'hypertensinn a tt riezi --du sujet jeune, dqal Omè nt inactif dans les f O--41noua -. tension aï't?i3.1é nevèreg comme dansées -hyt;n:1sf.ons ar= =:i=ce¯-1 térialles surv!,;- chez des sa jets neurotaniques, il a une '101' clouce et progrossive sur les 'iliypertersions cÇOnmT';.mea. ".
"Seaci.'tquantsine':-- '' - ¯ ¯ -. - ;=.i;g' -sur le-plan dé 3.a tolérance i. n'a cependant jamais étiez -.:'::-:eonatâté d .ë:ffet$ secondaires -tels qu'on les 'renconùe " .
<.,'la' réserpine ou ses analogues strilcturaux. plus parti(n:<liè----'- 5 -rament, on n'a jam,-aîs -not <3e. congestion, ocl-nasale de i sécheresse de la bouche ou !1..excitaion, de,7complîcationa '::9aBtro-irite5inalf'e "ty#é ulcêretax, nota±ment, érptiqns ?,]¯utan4s,- -de rétention "êe;'sur ce plan au contraire, le . :.--produit selon leirvention-exerce plutôt une action diurétiçùµ(1' n9a jamais été poté non -1lus de ênoBns d'hypotesiGn 13n x6sum6, le priait selon 3.'iR?enti<Mse présente "98#/)ù )µµtjflj']1,Q ihdicaiùeùt-de 1"4yportension de la-ce râqu antaine jS lt,n:7iLits1tt;co";
<Desc/Clms Page number 5>
EMI5.1
dairou *Qa réscrpiniquea" prd;e'ee-a4on n 0 -4* u n"> A.,, i.) ort nouveau et sane inconvénients pour la thérapeutique de la malaidie hypertonsive REVENDICATIONS
EMI5.2
1. Nouvoau m6diamont hypote13aizir. -covtitu6 par le ,, 3 -.rhc:c de dim6thylaminortz:a .
2. Procédé pour la px'<6payatioa du 113 ,5..t:dmé'1:!QXY'" benzoate do Ctli#l".r.'TClYïQEi3â.ïlC>,i taractÓris6 en ce qu'on fait r6a9ir l'acide 1 d 3 a-t3.rsHrrct sur le calo- rure de di6thylaroinoéthyle en solixtton 6ans la m6thylathyl--
**ATTENTION** fin du champ DESC peut contenir debut de CLMS **.
Claims (1)
- cétone à l'ébullition sans reflux. **ATTENTION** fin du champ CLMS peut contenir debut de DESC **.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR58114A FR5936M (fr) | 1956-12-19 | 1956-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE697097A true BE697097A (fr) | 1967-10-02 |
Family
ID=8606545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE697097D BE697097A (fr) | 1956-12-19 | 1967-04-17 |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE697097A (fr) |
| ES (1) | ES338525A1 (fr) |
| FR (1) | FR5936M (fr) |
-
1956
- 1956-12-19 FR FR58114A patent/FR5936M/fr not_active Expired
-
1967
- 1967-03-27 ES ES338525A patent/ES338525A1/es not_active Expired
- 1967-04-17 BE BE697097D patent/BE697097A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES338525A1 (es) | 1968-04-01 |
| FR5936M (fr) | 1968-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110627925B (zh) | 一种精制舒更葡糖钠的方法 | |
| FI59077C (fi) | Foerfarande foer rening av vaotprocessfosforsyra | |
| BE697097A (fr) | ||
| WO2024082154A1 (fr) | Procédé de préparation de produit brut de sucralose à l'aide d'un système d'hydrolyse amélioré | |
| WO2024130897A1 (fr) | Procédé de préparation de crotononitrile | |
| US3947496A (en) | Process for recovering glycine from sodium sulfate solutions | |
| EP4251605A1 (fr) | Procédé respectueux de l'environnement pour l'acylation sélective d'aminophénol | |
| CH405264A (fr) | Procédé de préparation des mercapto-succinates de bases azotées | |
| US2806890A (en) | Recovering trimethylolethane by ethyl acetate extraction | |
| CN110698398A (zh) | 一种米库氯铵的纯化方法 | |
| Marsden Jr et al. | X-ray diffraction in aqueous systems of dodecyl sulfonic acid | |
| US950936A (en) | Process of making the n-propyl ester of p-aminobenzoic acid. | |
| SU67145A1 (ru) | Способ получени кристаллической глюкозы | |
| US2182075A (en) | Water soluble derivatives of p-aminobenzenesulphonamide | |
| Haworth et al. | LXXXVI.—Crystalline α-methylmannofuranoside (γ-methylmannoside). Part I | |
| Smith | Preparation of pure gossypol from dianilinogossypol | |
| US3113128A (en) | Process for the manufacture of dihydrostrophanthin | |
| SU762908A1 (ru) | Способ конденсации вторичного пара при кристаллизации веществ из растворов 1 | |
| WO2014106419A1 (fr) | Procédé de synthèse de 1-méthyl-2-oxo-3,6,7-trioxabicyclo[2,2,2]octane | |
| JPS5538305A (en) | Preparation of hedta | |
| JPS54144314A (en) | Recovery of lysine | |
| SU75854A1 (ru) | Способ получени ортофенантролина | |
| US1780860A (en) | Betainethiocyanate | |
| GB658766A (en) | Improvements in and relating to the purification of antibiotics | |
| Yabuta et al. | Preparation of Furanethylamine |